Pubblicazioni

A POPULATION-BASED STUDY OF MYELODYSPLASTIC SYNDROMES PATIENTS IN THE LAZIO REGION (ITALY), MISCODING IN MEDICAL CLAIMS AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

2015 - HAEMATOLOGICA

Mayer, F; Fenu, S; Agabiti, N; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, Maa; Breccia, M; Cimino, G; Fianchi, L; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, Al; Tafuri, A; Trape, G; Voso, Mt; Davoli, M; Zini, G

UNFAVORABLE KARYOTYPE AND MOLECULAR NEGATIVITY SIGNIFICANTLY INFLUENCE THE INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

2015 - HAEMATOLOGICA

Polverelli, N; Breccia, M; Benevolo, G; Latagliata, R; Catani, L; Perricone, M; Sollazzo, D; Colafigli, G; Nicolosi, M; Campana, A; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

DASATINIB FIRST-LINE: UPDATE DI UNA ESPERIENZA "REAL-LIFE" ITALIANA

2015 - HAEMATOLOGICA

Breccia, M; Annunziata, M; Nardiello, I; Maggi, A; Sgherza, N; Russo-Rossi, A; Pregno, P; Castagnetti, F; Iurlo, A; Latagliata, R; Cedrone, M; Di Renzo, N; Sora, F; Rege-Cambrin, G; Caocci, G; Scortechini, Ar; Greco, G; Franceschini, L; Sica, S; Bocchia, M; Crugnola, M; Orlandi, E; Stagno, F; Luciano, L; Abruzzese, E; Rosti, G; Specchia, G; Guarini, A; Saglio, G; Alimena, G

INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

2015 - HAEMATOLOGICA

Polverelli, N; Breccia, M; Benevolo, G; Latagliata, R; Catani, L; Nicolosi, M; Perricone, M; Sollazzo, D; Romano, M; Colafigli, G; Forte, D; Campana, A; Testoni, N; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

Very Elderly Patients with Chronic Phase-Chronic Myeloid Leukemia on Imatinib: No Impact of Concomitant Drugs on Complete Cytogenetic Response

2015 - BLOOD

Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Cattaneo, D; Fava, C; Gozzini, A; Annunziata, M; Tiribelli, M; Pregno, P; Stagno, F; Vigneri, P; Cavazzini, F; Binotto, G; Mansueto, G; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Gasbarrino, C; D'Addosio, A; Cortesi, L; Cedrone, M; Rossi, Ar; Avanzini, P; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Rege-Cambrin, G; Sica, S; Luciano, L; Orlandi, Em; Bocchia, M; Tettamanti, M; Alimena, G; Saglio, G; Rosti, G; Nobili, A; Mannucci, Pm; Cortelezzi, A

Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial

2015 - BLOOD

Breccia, M; Castagnetti, F; Gugliotta, G; Martino, B; Rossi, G; Carella, Am; Stagno, F; Turri, D; Avanzini, P; Trabacchi, E; Pierri, I; Tiribelli, M; Isidori, A; Salvucci, M; Capalbo, S; Merli, A; Levato, L; Binotto, G; Maino, E; Rupoli, S; Pane, F; Saglio, G; Baccarani, M; Alimena, G; Rosti, G

VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY?

2015 - HAEMATOLOGICA

Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A

APPLICATION OF CARDIOVASCULAR RISK ASSESSMENT IN CHRONIC PHASE CML PATIENTS TREATED WITH NILOTINIB ALLOWS IDENTIFICATION OF SUBJECTS AT HIGH RISK OF EVENTS

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Quattrocchi, L; Saracino, R; Alimena, G

ACCURACY OF PHYSICIAN ASSESSMENT OF TREATMENT PREFERENCES AND HEALTH STATUS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES

2015 - HAEMATOLOGICA

Caocci, G; Voso, Mt; Angelucci, E; Stauder, R; Cottone, F; Abel, G; Nguyen, Ktt; Platzbecker, U; Beyne-Rauzy, O; Gaidano, G; Invernizzi, R; Molica, S; Criscuolo, M; Breccia, M; Lubbert, M; Sanpaolo, G; Buccisano, F; Ricco, A; Palumbo, G; Niscola, P; Zhang, H; Fenu, S; La Nasa, G; Mandelli, F; Efficace, F

PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING AZACYTIDINE TREATMENT

2015 - HAEMATOLOGICA

Latagliata, R; De Angelis, F; De Luca, Ml; Carmosino, I; Vozella, F; Montagna, C; Romano, A; Petrucci, L; Salaroli, A; Molica, M; Colafigli, G; Mancini, M; Breccia, M; Alimena, G; Girmenia, C

Age and Gender-Related Pretreatment Quality of Life Profiles in Patients with Higher-Risk Myelodysplastic Syndromes. Establishing Benchmark Data from an International Study

2015 - BLOOD

Efficace, F; Gaidano, G; Breccia, M; Niscola, P; Cottone, F; Fianchi, L; Voso, Mt; Caocci, G; Buccisano, F; Angelucci, E; Santini, V; Stauder, R; Platzbecker, U; Ricco, A; Di Renzo, N; Bowen, D; Mandelli, F

OUTCOME OF AZACITIDINE TREATMENT AND INCIDENCE OF FEBRILE EVENTS IN "REAL WORLD" PATIENTS WITH MDS OR LOW-BLAST COUNT AML

2015 - LEUKEMIA RESEARCH

Voso, Mt; Niscola, P; Piciocchi, A; Fianchi, L; Maurillo, L; Musto, P; Pagano, L; Mansueto, G; Criscuolo, M; Aloe-Spiriti, Ma; Buccisano, F; Venditti, A; Tendas, A; Piccioni, Al; Zini, G; Latagliata, R; Filardi, N; Fragasso, R; Fenu, S; Breccia, M

Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis

2015 - BLOOD

Tavares, R; Palumbo, Ga; Le Coutre, P; Palanciri, F; Al-Ali, Hk; Martino, B; Liberati, Am; Arich, Jc; Breccia, M; Brittain, D; Foltz, L; Griesshammer, M; Raanani, P; Gupta, V; Giraldo, P; Chosh, J; Tannir, B; Ronco, Jp; Vannucchi, Am

PROGNOSTIC FACTORS ASSOCIATED TO ACHIEVEMENT OF STABLE MR4.5 IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FIRST-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Stagno, F; Rege-Cambrin, G; Carella, Am; Luciano, L; Specchia, G; Abruzzese, E; Martino, B; Usala, E; Rossi, G; Bocchia, M; Cavazzini, F; Tiribelli, M; Venturi, C; Soverini, S; Alimena, G; Cavo, M; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

A RETROSPECTIVE MULTICENTRE COMPARISON OF INTENSIVE CHEMOTHERAPY WITH AZACITIDINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS

2015 - HAEMATOLOGICA

Maurillo, L; Buccisano, F; Voso, Mt; Fianchi, L; Papayannidis, C; Gaidano, Gl; Breccia, M; Musto, R; Di Veroli, A; Martinelli, G; Lunghi, M; Lessi, F; Del Principe, Mi; Ramadan, Sm; Suciu, S; Amadori, S; Venditti, A

Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?

2015 - HEMATOLOGICAL ONCOLOGY

Vozella, F; Latagliata, R; Carmosino, I; Volpicelli, P; Montagna, C; Romano, A; Roberto, A; Finsinger, P; Mancini, M; Breccia, M; Oliva, E; Alimena, G

DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CHRONIC MYELOID LEUKEMIA

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Rossi, G; Stagno, F; Turri, D; Pregno, P; Tiribelli, M; Trabacchi, E; Martino, B; Carella, Am; Isidori, A; Pierri, I; Salvucci, M; Specchia, G; Levato, L; Avanzini, P; Capalbo, S; Merli, A; Maino, E; Binotto, G; Bochicchio, Mt; Soverini, S; Cavo, M; Alimena, G; Martinelli, G; Saglio, G; Pane, F; Baccarani, M; Rosti, G

Long-Term Follow-up in Very Elderly Patients with Chronic Myeloid Leukemia Treated with Imatinib Frontline

2015 - BLOOD

Latagliata, R; Breccia, M; Ferrero, D; Cavazzini, F; Trawinska, Mm; Castagnetti, F; Annunziata, M; Stagno, F; Tiribelli, M; Binotto, G; Fava, C; Crisa, E; Mansueto, G; Gozzini, A; Falzetti, F; Montefusco, E; Iurlo, A; Sabina, R; Cedrone, M; Rossi, Ar; Gugliotta, G; Pregno, P; Isidori, A; Avanzini, P; Endri, M; Romano, A; Giglio, G; Celesti, F; Sora, F; Storti, S; D'Addosio, A; Galimberti, S; Orlandi, Em; Calistri, E; Bocchia, M; Crugnola, M; Cambrin, Gr; Vigneri, P; Luciano, L; Abruzzese, E; Alimena, G

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

2015 - LEUKEMIA

Lengfelder, E; Lo-Coco, F; Ades, L; Montesinos, P; Grimwade, D; Kishore, B; Ramadan, Sm; Pagoni, M; Breccia, M; Huerta, Ajg; Nloga, Am; Gonzalez-Sanmiguel, Jd; Schmidt, A; Lambert, Jf; Lehmann, S; Di Bona, E; Cassinat, B; Hofmann, Wk; Gorlich, D; Sauerland, Mc; Fenaux, P; Sanz, M

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FRONTLINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Stagno, F; Rege-Cambrin, G; Carella, Am; Luciano, L; Abruzzese, E; Martino, B; Usala, E; Rossi, G; Bocchia, M; Cavazzini, F; Tiribelli, M; Luatti, S; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

Ponatinib in chronic myeloid leukaemia: ready for first-line?

2015 - THE LANCET. HAEMATOLOGY

Breccia, M; Alimena, G

Risk Factors for Infections in Myelofibrosis: Role of Disease Status and Treatment. A Study on 507 Patients

2015 - BLOOD

Polverelli, N; Breccia, M; Benevolo, G; Martino, B; Tieghi, A; Latagliata, R; Catani, L; Nicolosi, M; Perricone, M; Romano, M; Colafigli, G; Campana, A; Merli, F; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes

2015 - LEUKEMIA RESEARCH

Caocci, G; Voso, Mt; Angelucci, E; Stauder, R; Cottone, F; Abel, G; Nguyen, K; Platzbecker, U; Beyne-Rauzy, O; Gaidano, G; Invernizzi, R; Molica, S; Criscuolo, M; Breccia, M; Lubbert, M; Sanpaolo, G; Buccisano, F; Ricco, A; Palumbo, Ga; Niscola, P; Zhang, H; Fenu, S; La Nasa, G; Mandelli, F; Efficace, F

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment

2015 - BLOOD CANCER JOURNAL

Russo, D; Malagola, M; Skert, C; Cancelli, V; Turri, D; Pregno, P; Bergamaschi, M; Fogli, M; Testoni, N; De Vivo, A; Castagnetti, F; Pungolino, E; Stagno, F; Breccia, M; Martino, B; Intermesoli, T; Cambrin, Gr; Nicolini, G; Abruzzese, E; Tiribelli, M; Bigazzi, C; Usala, E; Russo, S; Russo-Rossi, A; Lunghi, M; Bocchia, M; D'Emilio, A; Santini, V; Girasoli, M; Di Lorenzo, R; Bernardi, S; Di Palma, A; Cesana, Bm; Soverini, S; Martinelli, G; Rosti, G; Baccarani, M